查看购物车
  • Traditional Chinese
  • English
封面
市场调查报告书
商品编码
1654676

全球血管摄影机市场 - 2025 至 2033 年

Global Angiography Machine Market - 2025-2033
出版日期: | 出版商: DataM Intelligence | 英文 149 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

2024 年全球血管摄影机市场规模达到 113 亿美元，预计到 2033 年将达到 190 亿美元，2025-2033 年预测期内的复合年增长率为 6.0%。

血管摄影机是一种专门的医学影像系统，用于即时显示身体的血管、动脉和静脉。它利用 X 光、CT 或 MRI 技术，通常与造影剂结合使用，来检测阻塞、动脉瘤和血管畸形等异常情况。这台血管摄影机是现代医学中重要的诊断和介入工具，可即时可视化血管，以诊断和治疗各种心血管和神经系统疾病。其发展包括基于人工智慧的成像、混合系统和移动单元，提高了医疗诊断的可及性和准确性。

由于多种关键因素，包括心血管疾病发病率上升、技术进步以及微创手术的日益普及，对血管造影机的需求正在迅速增长。例如，根据美国疾病管制与预防中心的数据，每 33 秒就有一人死于心血管疾病。 2022 年，有 702,880 人死于心臟病。这相当于每5人死亡就有1人。随着心血管疾病的增加，对用于诊断冠状动脉疾病、週边动脉疾病和其他血管问题的血管摄影机的需求激增。

市场动态：

驱动因素与约束因素

科技进步日新月异

不断进步的技术极大地推动了血管造影机市场的成长，预计将在预测期内推动市场的发展。这些创新正在提高诊断的准确性，最大限度地降低患者风险并提高效率，使血管造影机更容易获得和更受欢迎。 3D 血管摄影彻底改变了血管的可视化方式。这些技术可以更好地可视化复杂的血管结构，这对于血管手术和支架植入尤其重要。

例如，2022 年 9 月，西门子医疗在印度推出了血管摄影系统 ARTIS icono。血管造影系统具有大大改进的二维和三维成像能力，从而提高了影像品质并降低了辐射需求。透过正弦旋转，颅底和颅盖可以以 3D 形式呈现，并且几乎不会产生任何伪影，从而改善 C 臂的运动。 ARTIS icono Biplane 将协助中风中心应对治疗更多患者、更快、更精确的综合挑战。

人工智慧 (AI) 演算法现已整合到血管造影系统中，以协助放射科医生自动检测血管阻塞、动脉瘤或狭窄等异常情况。例如，人工智慧技术被纳入平板侦测器 (FPD) 血管造影系统，以提高影像清晰度和血管异常的自动侦测能力，减少人为错误并提高诊断准确性。

辐射暴露问题

虽然血管摄影仍然是血管疾病最有效的诊断和介入工具之一，但对辐射暴露的担忧是限制其发展的重要因素。这些问题影响着患者和医疗保健专业人员，并影响血管造影机的采用和使用。

长期或反覆暴露于血管摄影仪的辐射会增加放射线诱发癌症、皮肤损伤和其他长期健康问题的风险。对于因冠状动脉疾病 (CAD) 等慢性疾病而需要频繁接受血管摄影检查的患者来说，这尤其令人担忧。

例如，接受冠状动脉造影的患者随着时间的推移会面临累积高剂量辐射的风险，这可能导致癌症风险。 《美国心臟病学会杂誌》（JACC）发表的一项研究发现，重复进行心臟血管造影所造成的高累积辐射暴露可能使普通患者一生中患癌症的风险增加高达 1.4%。

随着对辐射引起的健康风险的认识不断增强，患者可能变得不愿意接受血管造影手术，特别是在需要重复扫描或存在 CT 血管造影或 MRI 血管造影等替代成像方法的情况下。这可以减少某些医疗机构对血管摄影机的需求。

目录

第一章：市场介绍和范围

  • 报告目标
  • 报告范围和定义
  • 报告范围

第 2 章：高阶主管见解与关键要点

  • 市场亮点和战略要点
  • 主要趋势和未来预测
  • 按产品类型分类的片段
  • 技术片段
  • 按应用程式截取的程式码片段
  • 最终用户的程式码片段
  • 按地区分类的片段

第 3 章：动态

  • 影响因素
    • 驱动程式
      • 不断进步的技术
    • 限制
      • 辐射暴露问题
    • 机会
    • 影响分析

第四章：战略洞察与产业展望

  • 市场领导者和先驱者
    • 新兴先锋和杰出参与者
    • 拥有最大销售品牌的成熟领导者
    • 拥有成熟产品的市场领导者
  • 新兴创业公司和关键创新者
  • CXO 观点
  • 最新进展与突破
  • 案例研究/正在进行的研究
  • 监管和报销情况
    • 北美洲
    • 欧洲
    • 亚太地区
    • 拉丁美洲
    • 中东和非洲
  • 波特五力分析
  • 供应链分析
  • 专利分析
  • SWOT 分析
  • 未满足的需求和差距
  • 市场进入和扩张的推荐策略
  • 情境分析：最佳情况、基本情况和最坏情况预测
  • 定价分析和价格动态

第 5 章：血管摄影机市场（依产品类型）

  • X光血管摄影机
  • CT 血管摄影机
  • 磁振造影血管摄影机
  • 其他的

第 6 章：血管造影机市场（依技术划分）

  • 二维血管摄影
  • 3D 血管摄影
  • 旋转血管摄影
  • 其他的

第 7 章：血管摄影机市场（按应用）

  • 冠状动脉造影
  • 脑血管摄影
  • 肺血管摄影
  • 肾臟血管摄影
  • 腹部血管摄影
  • 肢体血管摄影

第 8 章：血管摄影机市场（依最终用户划分）

  • 医院
  • 专科诊所
  • 诊断中心
  • 外科中心
  • 其他的

第 9 章：血管造影机市场，按区域市场分析和成长机会

  • 北美洲
    • 我们
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 西班牙
    • 义大利
    • 欧洲其他地区
  • 南美洲
    • 巴西
    • 阿根廷
    • 南美洲其他地区
  • 亚太
    • 中国
    • 印度
    • 日本
    • 韩国
    • 亚太其他地区
  • 中东和非洲

第 10 章：竞争格局与市场定位

  • 竞争概况和主要市场参与者
  • 市占率分析与定位矩阵
  • 策略伙伴关係、併购
  • 产品组合和创新的关键发展
  • 公司基准化分析

第 11 章：公司简介

  • Siemens Healthineers AG
    • 公司概况
    • 产品组合和描述
    • 财务概览
    • 关键进展
    • SWOT 分析
  • Canon Medical Systems ANZ Pty Limited.
  • GE HealthCare
  • Shimadzu Corporation
  • Koninklijke Philips NV
  • B. Braun SE

第 12 章：假设与研究方法

  • 资料收集方法
  • 数据三角测量
  • 预测技术
  • 数据验证和确认

第 13 章：附录

简介目录
Product Code: MD9110

The global angiography machine market reached US$ 11.3 billion in 2024 and is expected to reach US$ 19.0 billion by 2033, growing at a CAGR of 6.0% during the forecast period 2025-2033.

An angiography machine is a specialized medical imaging system used to visualize the blood vessels, arteries, and veins of the body in real time. It utilizes X-ray, CT, or MRI technology, often combined with a contrast agent, to detect abnormalities such as blockages, aneurysms and vascular malformations. This angiography machine is a critical diagnostic and interventional tool in modern medicine, enabling real-time visualization of blood vessels to diagnose and treat various cardiovascular and neurological conditions. Its evolution includes AI-based imaging, hybrid systems, and mobile units, improving accessibility and accuracy in medical diagnostics.

The demand for angiography machines is growing rapidly due to several key factors, including the rising prevalence of cardiovascular diseases, advancements in technology, and the increasing adoption of minimally invasive procedures. For instance, acording to the Centers for Disease Control and Prevention, one person dies every 33 seconds from cardiovascular disease. In 2022, 702,880 people died from heart disease. That's the equivalent of 1 in every 5 deaths. As the cardiovascular diseases increase, demand for angiography machines has surged to diagnose coronary artery disease, peripheral artery disease and other vascular issues.

Market Dynamics: Drivers & Restraints

Rising technological advancements

The rising technological advancements is significantly driving the growth of the angiography machine market and is expected to drive the market over the forecast period. These innovations are improving diagnostic accuracy, minimizing patient risk and enhancing efficiency, making angiography machines more accessible and desirable. 3D angiography have revolutionized the way blood vessels are visualized. These technologies allow for better visualization of complex vascular structures, which is especially important for vascular surgeries and stent placements.

For instance, in September 2022, Siemens Healthineers launched ARTIS icono, an angiography system, in India. The angiography system has much improved 2D and 3D imaging capabilities, which improve picture quality and reduce radiation requirements. The cranial base and skull cap may be portrayed in 3D with virtually no artifacts to improved C-arm movement with Sine Spin. ARTIS icono Biplane will assist stroke centers in meeting the combined challenge of treating more patients, faster, and with more precision.

Artificial Intelligence (AI) algorithms are now being integrated into angiography systems to assist radiologists in automatically detecting abnormalities such as blockages, aneurysms, or stenosis in blood vessels. For instance, AI technologies are being incorporated into flat-panel detector (FPD) angiography systems to enhance image clarity and automatic detection of vascular anomalies, reducing human error and improving diagnostic accuracy.

Radiation exposure concerns

While angiography remains one of the most effective diagnostic and interventional tools for vascular diseases, concerns over radiation exposure are a significant factor limiting its growth. These concerns affect both patients and healthcare professionals, influencing the adoption and utilization of angiography machines.

Prolonged or repeated exposure to radiation from angiography machines can increase the risk of radiation-induced cancers, skin damage and other long-term health issues. This is particularly concerning for patients who require frequent angiography procedures for chronic conditions like coronary artery disease (CAD).

For instance, patients undergoing coronary angiography are at risk of accumulating high doses of radiation over time, which can lead to cancer risks. A study published in JACC (Journal of the American College of Cardiology) found that high cumulative radiation exposure from repeated cardiac angiography could raise the lifetime risk of cancer by up to 1.4% for a typical patient.

As awareness about radiation-induced health risks grows, patients may become hesitant to undergo angiography procedures, especially in the case of repeated scans or when alternative imaging methods like CT angiography or MRI angiography exist. This can reduce the demand for angiography machines in certain healthcare settings.

Segment Analysis

The global angiography machine market is segmented based on product type, technology, application, end-user and region.

Application:

The coronary angiography segment is expected to dominate the angiography machine market share

Cardiovascular diseases are the leading cause of death worldwide, with coronary artery disease (CAD) being one of the most common types of heart disease. As the global population ages and lifestyle-related risk factors such as obesity, diabetes, and smoking increase, there is a corresponding rise in the demand for coronary angiography to detect and treat these conditions.

For instance, the World Health Organization (WHO) reports that cardiovascular diseases account for 32% of global deaths, with coronary artery disease (CAD) being a major contributor. This has led to a high demand for coronary angiography as the gold standard for diagnosing blockages and narrowing of coronary arteries.

Coronary angiography is considered the gold standard for diagnosing coronary artery disease (CAD), providing a clear view of the coronary arteries, allowing cardiologists to evaluate blockages, stenosis, and the need for interventional procedures. For instance, in North America and Europe, coronary angiography is widely used in cardiac catheterization labs (Cath Labs) for diagnosis and treatment planning of patients with chest pain, shortness of breath, or risk factors for CAD, making it the dominant use case for angiography systems in these regions.

Geographical Analysis

North America is expected to hold a significant position in the angiography machine market share

North America particularly the United States is a hub for innovation in medical imaging technologies, and this extends to the angiography market. Continuous advancements in 3D imaging, digital subtraction angiography, real-time image guidance and AI integration have positioned North America at the forefront of adopting next-generation angiography systems.

For instance, Philips Healthcare and GE Healthcare, two major players in the angiography market, have developed cutting-edge systems such as the Philips Azurion and GE Innova platforms, which offer superior imaging clarity and reduced radiation exposure. These advanced systems are widely used across North America in cardiology, vascular surgery, and interventional radiology.

North America leads the adoption of hybrid angiography systems that combine traditional angiography with CT, MRI, or 3D imaging to provide a more comprehensive diagnostic approach. These systems offer real-time imaging and guidance, making them particularly useful for minimally invasive procedures like angioplasty, stent placement, and neurovascular interventions.

For instance, the growing trend of hybrid operating rooms, particularly in U.S. hospitals, is a key factor driving the demand for advanced angiography machines. Hybrid ORs integrate angiography systems with CT/MRI imaging, providing the flexibility to perform complex procedures like cardiac bypass surgeries and endovascular aneurysm repairs in a single setting.

Asia-Pacific is growing at the fastest pace in the angiography machine market

Cardiovascular diseases are on the rise in Asia-Pacific due to aging populations, urbanization, and the growing prevalence of risk factors such as smoking, poor diet, and lack of physical activity. As a result, there is an increasing demand for angiography as a diagnostic tool to detect and treat conditions like coronary artery disease (CAD), stroke, and peripheral artery disease (PAD).

For instance, in China, heart disease is the leading cause of death, with a significant rise in coronary artery disease cases, prompting the need for advanced diagnostic tools like angiography. According to the World Health Organization (WHO), more than 4 million deaths in China are attributed to CVDs, leading to growing demand for angiography procedures.

Medical tourism in APAC is also contributing to the growth of the angiography machine market, as countries like India, Thailand, and Singapore attract patients from developed countries seeking affordable, high-quality medical care. Many international patients travel to APAC for heart surgeries, angioplasties, and angiography due to the region's cost-effectiveness and high-quality healthcare services.

For instance, India is a major medical tourism destination, especially for cardiac procedures. Hospitals in cities like New Delhi, Chennai, and Bangalore are equipped with state-of-the-art angiography systems to cater to both local and international patients.

Competitive Landscape

The major global players in the angiography machine market include Siemens Healthineers AG, Canon Medical Systems ANZ Pty Limited., GE HealthCare, Shimadzu Corporation, Koninklijke Philips N.V., B. Braun SE and among others.

Why Purchase the Report?

  • Pipeline & Innovations: Reviews ongoing clinical trials, product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
  • Product Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
  • Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
  • Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
  • Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
  • Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
  • Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
  • Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
  • Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
  • Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
  • Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
  • Post-market Surveillance: Uses post-market data to enhance product safety and access.
  • Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The global angiography machine market report delivers a detailed analysis with 58 key tables, more than 65 visually impactful figures, and 149 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2024

  • Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
  • Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
  • Technology & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
  • Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
  • Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
  • Supply Chain: Distribution and Supply Chain Managers.
  • Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
  • Academic & Research: Academic Institutions.

Table of Contents

1. Market Introduction and Scope

  • 1.1. Objectives of the Report
  • 1.2. Report Coverage & Definitions
  • 1.3. Report Scope

2. Executive Insights and Key Takeaways

  • 2.1. Market Highlights and Strategic Takeaways
  • 2.2. Key Trends and Future Projections
  • 2.3. Snippet by Product Type
  • 2.4. Snippet by Technology
  • 2.5. Snippet by Application
  • 2.6. Snippet by End-User
  • 2.7. Snippet by Region

3. Dynamics

  • 3.1. Impacting Factors
    • 3.1.1. Drivers
      • 3.1.1.1. Rising Technological Advancements
    • 3.1.2. Restraints
      • 3.1.2.1. Radiation Exposure Concerns
    • 3.1.3. Opportunity
    • 3.1.4. Impact Analysis

4. Strategic Insights and Industry Outlook

  • 4.1. Market Leaders and Pioneers
    • 4.1.1. Emerging Pioneers and Prominent Players
    • 4.1.2. Established leaders with largest selling Brand
    • 4.1.3. Market leaders with established Product
  • 4.2. Emerging Startups and Key Innovators
  • 4.3. CXO Perspectives
  • 4.4. Latest Developments and Breakthroughs
  • 4.5. Case Studies/Ongoing Research
  • 4.6. Regulatory and Reimbursement Landscape
    • 4.6.1. North America
    • 4.6.2. Europe
    • 4.6.3. Asia Pacific
    • 4.6.4. Latin America
    • 4.6.5. Middle East & Africa
  • 4.7. Porter's Five Force Analysis
  • 4.8. Supply Chain Analysis
  • 4.9. Patent Analysis
  • 4.10. SWOT Analysis
  • 4.11. Unmet Needs and Gaps
  • 4.12. Recommended Strategies for Market Entry and Expansion
  • 4.13. Scenario Analysis: Best-Case, Base-Case, and Worst-Case Forecasts
  • 4.14. Pricing Analysis and Price Dynamics

5. Angiography Machine Market, By Product Type

  • 5.1. Introduction
    • 5.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 5.1.2. Market Attractiveness Index, By Product Type
  • 5.2. X-ray Angiography Machines*
    • 5.2.1. Introduction
    • 5.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 5.3. CT Angiography Machines
  • 5.4. Magnetic Resonance Angiography Machines
  • 5.5. Others

6. Angiography Machine Market, By Technology

  • 6.1. Introduction
    • 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 6.1.2. Market Attractiveness Index, By Technology
  • 6.2. 2D Angiography*
    • 6.2.1. Introduction
    • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 6.3. 3D Angiography
  • 6.4. Rotational Angiography
  • 6.5. Others

7. Angiography Machine Market, By Application

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 7.1.2. Market Attractiveness Index, By Application
  • 7.2. Coronary Angiography*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Cerebral Angiography
  • 7.4. Pulmonary Angiography
  • 7.5. Renal Angiography
  • 7.6. Abdominal Angiography
  • 7.7. Extremity Angiography

8. Angiography Machine Market, By End-User

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 8.1.2. Market Attractiveness Index, By End-User
  • 8.2. Hospitals*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Specialty Clinics
  • 8.4. Diagnostic Centers
  • 8.5. Surgical Centers
  • 8.6. Others

9. Angiography Machine Market, By Regional Market Analysis and Growth Opportunities

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 9.1.2. Market Attractiveness Index, By Region
  • 9.2. North America
    • 9.2.1. Introduction
    • 9.2.2. Key Region-Specific Dynamics
    • 9.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 9.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 9.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 9.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.2.7.1. U.S.
      • 9.2.7.2. Canada
      • 9.2.7.3. Mexico
  • 9.3. Europe
    • 9.3.1. Introduction
    • 9.3.2. Key Region-Specific Dynamics
    • 9.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 9.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 9.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 9.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.3.7.1. Germany
      • 9.3.7.2. U.K.
      • 9.3.7.3. France
      • 9.3.7.4. Spain
      • 9.3.7.5. Italy
      • 9.3.7.6. Rest of Europe
  • 9.4. South America
    • 9.4.1. Introduction
    • 9.4.2. Key Region-Specific Dynamics
    • 9.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 9.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 9.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 9.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.4.7.1. Brazil
      • 9.4.7.2. Argentina
      • 9.4.7.3. Rest of South America
  • 9.5. Asia-Pacific
    • 9.5.1. Introduction
    • 9.5.2. Key Region-Specific Dynamics
    • 9.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 9.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 9.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 9.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.5.7.1. China
      • 9.5.7.2. India
      • 9.5.7.3. Japan
      • 9.5.7.4. South Korea
      • 9.5.7.5. Rest of Asia-Pacific
  • 9.6. Middle East and Africa
    • 9.6.1. Introduction
    • 9.6.2. Key Region-Specific Dynamics
    • 9.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 9.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 9.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

10. Competitive Landscape and Market Positioning

  • 10.1. Competitive Overview and Key Market Players
  • 10.2. Market Share Analysis and Positioning Matrix
  • 10.3. Strategic Partnerships, Mergers & Acquisitions
  • 10.4. Key Developments in Product Portfolios and Innovations
  • 10.5. Company Benchmarking

11. Company Profiles

  • 11.1. Siemens Healthineers AG*
    • 11.1.1. Company Overview
    • 11.1.2. Product Portfolio and Description
    • 11.1.3. Financial Overview
    • 11.1.4. Key Developments
    • 11.1.5. SWOT Analysis
  • 11.2. Canon Medical Systems ANZ Pty Limited.
  • 11.3. GE HealthCare
  • 11.4. Shimadzu Corporation
  • 11.5. Koninklijke Philips N.V.
  • 11.6. B. Braun SE

LIST NOT EXHAUSTIVE

12. Assumption and Research Methodology

  • 12.1. Data Collection Methods
  • 12.2. Data Triangulation
  • 12.3. Forecasting Techniques
  • 12.4. Data Verification and Validation

13. Appendix

  • 13.1. About Us and Services
  • 13.2. Contact Us